Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is therefore used to treat diseases that are characterized by excessive number of ... GaBi Online, 1 day ago
Sales decline 15.71% to Rs 0.59 crore Net Loss of Zenotech Laboratories reported to Rs 11.12 crore in the quarter ended December 2014 as against net loss of Rs 6.87 crore during the previous quarter ended December 2013. Sales declined 15.71% to Rs 0.59 crore ...Business Standard, 3 weeks ago
will hold a meeting of the Board of Directors of the Company on 2 February 2015, to consider and approve the unaudited financial results of the Company for the quarter ended 31 December 2014Powered by Capital Market - Live NewsBusiness Standard, 1 month ago
There are two ways of exerting one's strength: one is pushing down, the other is pulling up. - Booker T. Washington Any hopes of a fantastic Friday was dashed by the supply of paper in terms of Coal India OFS. Domestic institutions including LIC ...India Infoline, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!